Robert Lanza Insider Trading
Get free email notifications about insider trading for Robert Lanza.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Robert Lanza. Robert Lanza is a Chief Scientific Officer in Ocata Therapeutics, Inc. ($ACTC) and a VP - Med & Sci Development in Ocata Therapeutics, Inc. ($ACTC).
Address: 381 PLANTATION STREET WORCESTER 01605 MA
Companies in which Robert Lanza is an Insider
Ocata Therapeutics, Inc.
Trading Symbol: ACTCIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Robert Lanza: Chief Scientific Officer, VP - Med & Sci Development
Holdings: 300,000 shares
Latest Transaction: Feb 08 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Robert Lanza
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 08 2008 | ACTC | Ocata Therapeutics ... | Lanza Robert | Chief Scientific Of ... | Option Exercise | A | 0.21 | 4,000,000 | 840,000 | 4,000,000 | |
Feb 07 2007 | ACTC | Ocata Therapeutics ... | Lanza Robert | VP - Med & Sci Deve ... | Grant | A | 0.00 | 200,000 | 0 | 300,000 | 100 K to 300 K (+200.00 %) |
Sep 20 2006 | ACTC | Ocata Therapeutics ... | Lanza Robert | VP - Med & Sci Deve ... | Option Exercise | A | 0.28 | 100,000 | 28,000 | 1,235,417 | |
Sep 20 2005 | ACTC | Ocata Therapeutics ... | Lanza Robert | VP - Med & Sci Deve ... | Option Exercise | A | 2.20 | 250,000 | 550,000 | 250,000 | |
Jul 08 2005 | ACTC | Ocata Therapeutics ... | Lanza Robert | VP - Med & Sci Deve ... | Option Exercise | A | 0.85 | 500,000 | 425,000 | 500,000 |